https://www.avient.com/sites/default/files/2024-12/2024 Avient Executive Bios_Walter Ripplepdf.pdf
Ripple
is responsible for developing and leading the company’s global sustainability strategy.
Ripple began his current role in January 2019, leading corporate initiatives that help the
company achieve critical sustainability and performance goals.
Avient’s sustainability efforts
have been acknowledged by third party sustainability recognitions such as Newsweek’s
America’s Most Responsible Companies, Barron’s 100 Most Sustainable Companies, and USA
Today’s Climate Leader awards.
https://www.avient.com/sites/default/files/2025-04/WalterRipple_bio.pdf
Ripple
is responsible for developing and leading the company’s global sustainability strategy.
Ripple began his current role in January 2019, leading corporate initiatives that help the
company achieve critical sustainability and performance goals.
Avient’s sustainability efforts
have been acknowledged by third party sustainability recognitions such as Newsweek’s
America’s Most Responsible Companies, Barron’s 100 Most Sustainable Companies, and USA
Today’s Climate Leader awards.
https://www.avient.com/sites/default/files/2020-08/michaelgarratt.pdf
Garratt joined Avient in 2013 from Marmon Utility, a Berkshire Hathaway company, where
he served as president.
Garratt’s chemical career began with The Dow Chemical Company, where he served in
commercial and marketing roles in Canada and the United States.
https://www.avient.com/sites/default/files/2024-04/AmySanders_bio.pdf
She previously served as senior vice president and deputy chief legal officer, global operations
at Eaton Corporation, a power management company.
Sanders spent over 20
years at 3M Company with various roles of increasing responsibility, culminating as senior vice
president and deputy general counsel supporting global business operations for all segments
and manufacturing operations.
https://www.avient.com/sites/default/files/2021-06/avient-ir-presentation-june-2021-w-non-gaap-recs_0.pdf
Each of such adjustments has not yet occurred, are out of the Company's control and/or cannot be reasonably predicted.
For the same reasons, the Company is unable to address the probable significance of the
unavailable information.
Innovation is the lifeblood of a specialty company.
https://www.avient.com/investor-center/news/polyone-announces-fourth-quarter-and-full-year-2019-results
As the company disclosed in December, the
Commenting on the company's outlook, Mr.
Investor Contacts
https://www.avient.com/news/polyone-announces-record-fourth-quarter-and-full-year-2014-results
Investor Relations Contact:
Eric R.
Media Relations Contacts
Company Officers
https://www.avient.com/sites/default/files/AVNT February IR Presentation_w_Non-GAAP Recs.pdf
Pro Forma Financial Information
The Company acquired Avient Protective Materials (“Dyneema”) on September 1, 2022 (the “Acquisition Date”) and sold the Distribution segment on November 1, 2022.
ASHISH KHANDPUR
PRESIDENT & CEO
7
8
PORTFOLIO TRANSFORMATION
8
46%
66%
87%
100%
0%
20%
40%
60%
80%
100%
2005 2010 2015 2020 2023
%
o
f A
dj
us
te
d
EB
IT
D
A
Commodity JVs Distribution Performance Products & Solutions Specialty Businesses
Adjusted EBITDA from Specialty Applications
SUSTAINABILITY AS A GROWTH DRIVER
9
LONG-TERM REVENUE GROWTH DRIVERS
Sustainable
Solutions
Composites, Healthcare,
Asia / LATAM
Overlap
Other
60%+
Key Growth
Drivers
Total Company Revenue
Growth Drivers Long-Term
Growth Rate
Sustainable Solutions 8–12%
Composites 8–10%
Healthcare 8–10%
Asia / LATAM 5%
Other 0–2%
Avient 6%
END MARKET OBSERVATIONS
(% OF COMPANY SALES)
ENERGY
DEFENSE
TELECOMMUNICATIONS
HEALTHCARE
10
TRANSPORTATION
INDUSTRIAL
BUILDING &
CONSTRUCTION 9%
CONSUMER
PACKAGING
23%
11
REGIONAL OBSERVATIONS
(% OF COMPANY SALES)
11
Q 4 2023 RE S U LT S
Q4 2023 PERFORMANCE VS.
The presentation of these measures may be different from non-GAAP financial measures used by other companies.
https://www.avient.com/sites/default/files/2022-06/Maxxam FR Injection Molding Processing Guide.pdf
Drying non-halogenated materials is suggested.
2 hours @ 100 (38)
Moisture Range
(%)
Not required
https://www.avient.com/sites/default/files/2023-01/Mevopur Colorants _ Additives Brochure.pdf
Contact us to discuss the additive
solution most adapted to your healthcare product.
For more detailed information on Mevopur uses and restrictions see www.avient.com/healthcare-use-limitations-mevopur-products or contact your Avient sales representative.
1.844.4AVIENT
www.avient.com